Products and Services
-
According to SmartInhaler maker Adherium, the FDA has granted 510(K) clearance for the company’s SmartTouch sensor for use with AstraZeneca’s Symbicort MDI. The SmartTouch device, which fits over the inhaler, records and transmits inhaler usage… Read more . . .
-
Chinese inhaled drug developer and CDMO CF PharmTech has raised $65M in a Series D financing round led by Future Industry Investment Fund (managed by SDIC Fund Management), the company said. The money is to… Read more . . .
-
Propeller Health and GSK have announced that their December 2015 agreement for development of a sensor for use with the Ellipta dry powder inhaler has been expanded, and R&D activities related to the use of… Read more . . .
-
A US company is selling a device marketed under the name Loli-O that promises delivery of nebulized medication to a child in the form of a cloud that emerges around a lollipop while the child… Read more . . .
-
Laboratory automation company Astech Projects, which manufactures the Xelair, Xelize, and Xelox ranges of automated inhaler testing systems, has announced a recent transition to the ISO 9001:2015 revised international standard for Quality Management Systems (QMS).… Read more . . .
-
Lonza has announced the acquisition of Swiss contract micronization company Micro-Macinazione. The company recently completed its acquisition of Capsugel which had acquired US micronization specialist Powdersize in 2015. Capsugel announced an expansion of its micronization… Read more . . .
-
CDMO Aptuit, which provides inhaled drug development and clinical supply manufacturing services, will be acquired by German CRO Evotec for $300 million, the two companies have announced. Aptuit has about 750 employees at 3 sites… Read more . . .
-
Lonza’s acquisition of CDMO Capsugelfrom KKR for $5.5 billion, which was initially announced in December 2016, is now complete, the company said. In 2011, Pfizer sold Capsugel to KKR for just under $2.4 billion, and… Read more . . .
-
Intranasal drug developer Opiant Pharmaceuticals has signed an exclusive global licensing deal with Aegis Therapeutics for use of Aegis’ Intravail absorption enhancers with Opiant’s opioid antagonists, the company said. No financial terms were disclosed. Opiant… Read more . . .
-
DPI device developer Iconovo AB announced that it has raised €.2.3 million in an oversubscribed share issue, which the company will use to fund expansion of its services to include drug formulation development. As part… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden